Whether you're racing against clinical timelines or navigating complex compliance, Katalyze Data is your trusted partner. Our Statilyze VSCE offering is designed to fit your needs, scale with your goals, and deliver clarity when it matters most.
Statilyze by Katalyze Data
- Faster clinical trial reporting
- Smarter tech with Open-Source & GenAI
- Agile platform tailored to you
.png?width=500&height=500&name=Validated%20(3).png)
- Fully managed, validated environment
- SAS, R & Python tools
- Version control & GxP Compliance
- Cloud or on-prem deployment
- Global access for all user types
- Built to scale, priced to perform
- Plug in new OpenSource packages
- SAS Viya with GenAI
- Source-controlled workflows that grow with you
- Our solution is trusted by leading brands such as:
- Veramed, Orphalan and Moonlake
- Contact us using the form below to schedule a VSCE assessment and explore how we can help you future-proof your business
Future of Validated Statistical Computing Environments
The BioPharma industry faces a delicate balance between mitigating risks of a life-and-death nature and innovating to stay ahead of the curve, thereby developing life-changing treatments for millions worldwide.
At the pivot point of this balance lies the Statistical Computing Environment (SCE), which provides the platform for assessing the efficacy and safety of all new drug treatments to worldwide regulatory authorities.
This paper explores the intricacies of Validated SCEs and outlines the next steps in the ongoing evolution.
Product Brochure
Statilyze by Katalyze Data
The validated statistical computing environment that grows with you.
A selection of our Life Sciences clients
_logo.svg.png?width=300&name=National_Health_Service_(England)_logo.svg.png){kind=logo}
Improving data management, access and control with a Validated Statistical Computing Environment
Investing in a Clinical Digital Analytics platform enables compliance with regulatory requirements and unlocks enhanced analytics for a leading pharmaceutical company.
Industry Solution Brief
The Pharma & Life Sciences industry is undergoing rapid transformation, driven by the need for accelerated drug development, regulatory compliance, and data- driven innovation.